U.S. Metals and Mining Stock News

NYSE:BILL
NYSE:BILLSoftware

Assessing BILL Holdings (BILL) Valuation As Weak Billings And Costly Customer Growth Raise Questions

Recent analysis of BILL Holdings (BILL) has highlighted weak billings growth and a negative customer acquisition cost payback period, raising questions about how efficiently the company is converting sales and marketing spend into lasting customer relationships. See our latest analysis for BILL Holdings. At a share price of US$41.17, BILL has a 1 day share price return of 3.99%. However, the 30 day and year to date share price returns show declines of 12.39% and 18.57%, respectively, together...
NasdaqCM:CHCI
NasdaqCM:CHCIReal Estate

Comstock Holding Companies (CHCI) Margin Strength Tests Bullish Narratives After EPS Slows

Comstock Holding Companies (CHCI) just posted its FY 2025 third quarter numbers, with revenue of US$13.3 million and basic EPS of US$0.05, set against trailing twelve month revenue of US$55.8 million and EPS of US$1.39 that reflects earnings growth of 127.8% over the past year. Over the last few quarters, revenue has tracked between US$10.8 million and US$16.9 million, while quarterly EPS has moved from US$0.05 to US$1.04. This gives investors a clear view of how profitability has translated...
NYSE:TDS
NYSE:TDSWireless Telecom

Kerrisdale Stake And Leadership Change Reframe Telephone And Data Systems

Kerrisdale Advisers has taken a new position in Telephone and Data Systems (NYSE:TDS) as the company shifts its focus toward fiber broadband and infrastructure. TDS has been reshaping its portfolio, including divestitures in its wireless segment, as part of this business repositioning. The company has also announced the upcoming retirement of a senior executive responsible for strategy and corporate development. For you as an investor, NYSE:TDS now sits at the intersection of telecom...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) Posts Q4 EPS Loss That Tests Bullish Earnings Rebound Narrative

Semtech (SMTC) has wrapped up FY 2026 with fourth quarter revenue of US$274.4 million, a basic EPS loss of US$0.32, and net income excluding extra items showing a loss of US$29.8 million, keeping profitability in focus for investors. Over the past six quarters, the company has seen revenue move from US$236.8 million in FY 2025 Q3 to US$274.4 million in FY 2026 Q4, while quarterly basic EPS has swung between a profit of US$0.48 and a loss of US$0.32, creating a mixed backdrop for margins. With...
NYSE:BKKT
NYSE:BKKTCapital Markets

Bakkt (BKKT) Returns To EPS Loss In Q3 2025 Challenging Profitability Narrative

Bakkt (BKKT) just posted its FY 2025 results with third quarter revenue of US$402.2 million and a basic EPS loss of US$1.02, while trailing twelve month revenue sat at US$3.9 billion against a basic EPS loss of US$5.06. Over recent periods, revenue has ranged from US$214.5 million in Q4 2023 to US$1.8 billion in Q4 2024 and US$1.1 billion in Q1 2025, with EPS swinging between a loss of US$7.25 in Q4 2023 and a profit of US$1.18 in Q1 2025. This gives investors a mixed picture on earnings...
NasdaqGS:KLTR
NasdaqGS:KLTRSoftware

Kaltura (KLTR) Losses Narrow Again In Q3 FY 2025 Challenging Bearish Profitability Concerns

Kaltura FY 2025 earnings snapshot Kaltura (KLTR) has just posted its FY 2025 third quarter numbers, reporting revenue of US$43.9 million and a basic EPS loss of US$0.02, alongside net income excluding extra items of a US$2.6 million loss. The company’s recent quarterly revenue has moved from US$45.6 million in Q4 2024 to US$44.5 million in Q2 2025 and US$43.9 million in Q3 2025. Over the same period, basic EPS has ranged between a loss of US$0.07 and a loss of US$0.02. The latest figures...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

BOK Financial Treasury Shift Highlights Fee Income Focus In Kansas City

BOK Financial (NasdaqGS:BOKF) has promoted Andrew Black to Senior Vice President and Manager of Treasury Sales in Kansas City. Black will oversee a team focused on cash management and fraud protection solutions for clients in the region. The appointment reflects an internal leadership shift within the company’s treasury services group. BOK Financial, trading at $124.85, has seen its share price move 5.2% year to date and 24.3% over the past year, with a 48.9% return over three years and...
NYSE:EMN
NYSE:EMNChemicals

Does Eastman’s Cost Cuts And Kingsport Upside Change The Bull Case For EMN?

In its latest quarterly update, Eastman Chemical reported earnings per share above expectations but slightly missed on revenue, highlighted US$60 million of incremental 2025 earnings from its Kingsport methanolysis facility, raised its dividend for the 16th consecutive year, and returned about US$500 million via dividends and buybacks. The company also lifted its 2026 cost reduction target to US$125 million–US$150 million and withheld full-year EPS guidance, underscoring both internal...
NasdaqCM:AGEN
NasdaqCM:AGENBiotechs

Agenus (AGEN) Q3 Profit Of US$63.9 Million Tests Longstanding Loss-Making Narrative

Agenus (NasdaqCM:AGEN) has swung to a profit in Q3 FY 2025, reporting total revenue of US$30.2 million and EPS of US$2.00, with net income of US$63.9 million for the period. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 to US$26.8 million in Q4 2024 and then to US$30.2 million in Q3 2025, while EPS shifted from a loss of US$2.52 per share in Q2 2024 to a loss of US$2.00 in Q4 2024 and then to a profit of US$2.00 in Q3 2025, indicating a sharp turn in reported...
NYSE:AVD
NYSE:AVDChemicals

American Vanguard (AVD) Quarterly Loss Deepens Margin Concerns And Challenges Profitability Narrative

American Vanguard (AVD) opened FY 2025 with mixed results, reporting Q3 revenue of US$119.3 million and a basic EPS loss of US$0.43, while on a trailing twelve month basis revenue stood at US$530.1 million alongside a basic EPS loss of US$3.96. The company has seen quarterly revenue move between US$115.8 million and US$165.6 million over the past six reported quarters, with basic EPS losses ranging from US$0.03 to US$3.21. This highlights pressure on profitability even as the top line remains...
NYSE:FF
NYSE:FFOil and Gas

FutureFuel (FF) Q3 Loss Deepens Five Year Earnings Deterioration Narrative

FutureFuel (FF) opened FY 2025 with a tough third quarter, reporting revenue of US$22.7 million and a basic EPS loss of US$0.21 alongside a net loss of US$9.3 million, while the trailing twelve months show revenue of US$137.4 million and a basic EPS loss of US$0.79 tied to a net loss of US$34.6 million. Over recent quarters, the company has seen revenue move from US$72.4 million with EPS of US$0.22 in Q2 2024 to US$35.7 million with an EPS loss of US$0.24 in Q2 2025 and then to US$22.7...
NYSEAM:AREN
NYSEAM:ARENInteractive Media and Services

Arena Group Holdings (AREN) Posts US$6.9m Q3 Profit Testing Bullish Profitability Narrative

Arena Group Holdings (AREN) has just posted its FY 2025 third quarter numbers, with revenue of US$29.8 million and basic EPS of US$0.14, while trailing twelve month revenue came in at US$142.8 million and EPS at US$0.64. Over recent quarters the company has seen revenue move between US$27.2 million and US$45.0 million per period, with basic EPS ranging from a loss of US$0.24 to a profit of US$0.26, and trailing twelve month net income excluding extra items reaching US$30.5 million. For...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

A Look At Masimo (MASI) Valuation After Recent Share Price Rebound

Context for Masimo after recent share price moves Masimo (MASI) has been drawing investor attention after a strong month in the share price, with the stock closing at $175.97 and recent returns prompting closer scrutiny of its fundamentals. See our latest analysis for Masimo. Beyond the recent surge, Masimo’s share price return of 35.21% over the past 30 days and 29.66% over 90 days contrasts with a far more modest 4.64% one year total shareholder return. This suggests momentum has picked up...
NasdaqCM:HFFG
NasdaqCM:HFFGConsumer Retailing

HF Foods Group (HFFG) Earnings Slip Back To Loss Challenges Profitability Turnaround Narrative

HF Foods Group (HFFG) has just posted its FY 2025 third quarter numbers, with revenue at US$307 million and a basic EPS loss of US$0.02, while on a trailing 12 month basis revenue sits at about US$1.23 billion and basic EPS at a loss of US$0.86. The company has seen quarterly revenue move from US$302 million in Q2 FY 2024 to US$307 million in Q3 FY 2025, with basic EPS shifting across that period from roughly breakeven at US$0.00 in Q2 FY 2024 to a loss of US$0.02 in the latest quarter...
NasdaqGS:TRST
NasdaqGS:TRSTBanks

TrustCo Bank Corp NY (TRST) Net Margin Improvement Reinforces Bullish Narratives

TrustCo Bank Corp NY (TRST) has rounded out FY 2025 with fourth quarter revenue of US$47.8 million and basic EPS of US$0.85, backed by trailing twelve month revenue of US$186.3 million and EPS of US$3.26. Over the past year, revenue has moved from US$169.8 million to US$186.3 million on a trailing basis, while basic EPS has shifted from US$2.57 to US$3.26. This sets the scene for investors to focus on how net profit margins at 32.8% and recent earnings growth shape the quality of this...
NYSE:HUYA
NYSE:HUYAEntertainment

Huya (NYSE:HUYA) Swings Back To Q3 EPS Profit Challenging Ongoing Loss Concerns

HUYA (NYSE:HUYA) has posted its latest FY 2025 numbers with Q3 revenue of C¥1.7b and basic EPS of C¥0.04, giving investors an opportunity to reassess the streaming platform's earnings path. The company reported revenue of C¥1.5b in Q1 2025, C¥1.6b in Q2 2025, and C¥1.7b in Q3 2025, while basic EPS moved from C¥0.00 in Q1 to a loss of C¥0.02 in Q2 before returning to a profit of C¥0.04 in Q3. This presents a mixed picture on margins but offers a clearer view of where profitability pressure...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast Holdings (MVST) Breakeven EPS In Q3 2025 Tests Profitability Narratives

Microvast Holdings (MVST) has posted its latest FY 2025 numbers with Q3 revenue at US$123.3 million, basic EPS at a loss of US$0.00 per share, and net income at a loss of US$1.5 million, while the trailing twelve months show revenue of US$444.5 million and a loss per share of US$0.40. The company has seen quarterly revenue range from US$83.7 million to US$123.3 million over the last six reported periods. Over the same period, basic EPS has swung between a profit of US$0.19 and losses of up to...
NYSE:PBH
NYSE:PBHPharmaceuticals

How Prestige’s Media Agency Shift At Prestige Consumer Healthcare (PBH) Has Changed Its Investment Story

Prestige Consumer Healthcare recently appointed Horizon Media as its new media planning and buying agency after a four-month competitive review, aiming to enhance brand reach through data-driven audience targeting and optimized channel spending. This move signals Prestige’s push to sharpen its consumer insights and marketing efficiency, potentially reinforcing its position across key over-the-counter health categories. Next, we’ll examine how Horizon Media’s data-powered audience...
NYSE:LRN
NYSE:LRNConsumer Services

Will Rapid Earnings and Revenue Growth Change Stride's (LRN) Investment Narrative?

In recent years, Stride (NYSE: LRN), formerly K12, has delivered strong financial results, with annual revenue growing 14.6% over five years and earnings per share rising 45% annually over the past two years, significantly ahead of many peers. This sustained financial outperformance underscores Stride's growing presence in education technology and helps explain why investor attention has intensified around the company. We’ll now examine how Stride’s rapid earnings growth reshapes its...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Is It Too Late To Consider Golar LNG (GLNG) After Its Strong Multi Year Share Price Run?

Investors wondering if Golar LNG is still reasonably priced after a strong run, or if the easy gains are already behind it, can use this article to focus on what the current share price indicates about value. The stock recently closed at US$44.86, with returns of 3.3% over 30 days, 18.2% year to date and 31.0% over the last year. The past 3 years and 5 years show very large gains of 142.3% and 326.6% respectively. Recent coverage has centered on how Golar LNG is positioned within the energy...
NYSE:HHH
NYSE:HHHReal Estate

Do Diverging Moves Around Earnings Reveal a Turning Point in Howard Hughes' (HHH) Governance Story?

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...
NYSE:THC
NYSE:THCHealthcare

Tenet Healthcare (THC) Is Down 8.8% After Earnings Beat And Expanded Buybacks Has The Bull Case Changed?

Tenet Healthcare recently reported fourth-quarter 2025 results that exceeded consensus expectations, supported by stronger same-facility revenues, a favorable payer mix, higher patient acuity, and contributions from Ambulatory Care acquisitions, while also updating its 2026 revenue and earnings outlook and progress on its multi-billion-dollar share repurchase program. Alongside these results, the company’s capital allocation signals were underscored by US$1.40 billion of share repurchases...
NYSE:COUR
NYSE:COURConsumer Services

How Consumer365’s AI Course Endorsement Will Impact Coursera (COUR) Investors

Earlier in 2026, Consumer365 named Coursera as a leading platform in its Best AI Course Online coverage, spotlighting the company’s broad catalogue of AI programs created with universities and technology partners. The recognition emphasizes Coursera’s role in practical, certificate-based AI learning that blends academic content with hands-on projects and assessments, reinforcing its positioning in professional upskilling. We’ll now examine how Consumer365’s endorsement of Coursera’s AI...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After A Year Of Softer Share Price Momentum

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...